Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,23/142,291/18800,3.4760488079481704e-17,1.02141126704757e-13,6.66471686507664e-14,CD27/CD276/CD46/CD55/CD80/CD83/CXCL13/EPO/FSTL3/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/PLAUR/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/VCAM1,23
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,21/142,233/18800,6.34416936054389e-17,1.02141126704757e-13,6.66471686507664e-14,CD276/CD300A/CD46/CD55/CD80/CSF1/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,21
GO:0050870,GO:0050870,positive regulation of T cell activation,20/142,223/18800,4.04410806744471e-16,2.78197441659317e-13,1.81524058042497e-13,CD27/CD276/CD46/CD55/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/VCAM1,20
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,20/142,230/18800,7.38291720968735e-16,3.39614191645618e-13,2.21598537602045e-13,CD276/CD300A/CD46/CD55/CD80/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,20
GO:0042098,GO:0042098,T cell proliferation,19/142,204/18800,1.1491938093736901e-15,3.84264791695713e-13,2.50733090625905e-13,CD276/CD46/CD55/CD80/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,19
GO:0050863,GO:0050863,regulation of T cell activation,23/142,342/18800,1.1933689183096702e-15,3.84264791695713e-13,2.50733090625905e-13,CD27/CD276/CD300A/CD46/CD55/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/TNFRSF1B/VCAM1/VSIG4,23
GO:0032943,GO:0032943,mononuclear cell proliferation,21/142,300/18800,1.0436073304997e-14,2.8003463368408697e-12,1.82722827340123e-12,CD276/CD300A/CD46/CD55/CD80/CSF1/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,21
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,23/142,381/18800,1.21672357160019e-14,2.9505820935672996e-12,1.92525722744699e-12,CD27/CD276/CD300A/CD46/CD55/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/JAM2/LGALS9/LILRB4/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/VCAM1/VSIG4,23
GO:0050867,GO:0050867,positive regulation of cell activation,23/142,436/18800,2.09959032500625e-13,3.21937183167625e-11,2.1006427512343198e-11,ACTA2/CD27/CD276/CD46/CD55/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/NECTIN2/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/TNFRSF4/VCAM1,23
GO:0002685,GO:0002685,regulation of leukocyte migration,15/142,218/18800,1.06215068518632e-10,1.42505216929164e-08,9.29847705101706e-09,CCL20/CCN3/CD300A/CSF1/CXCL13/F7/IL6/JAM2/LGALS9/NBL1/PGF/PTN/THY1/TNFRSF14/VEGFA,15
GO:0050900,GO:0050900,leukocyte migration,18/142,384/18800,7.14899680146784e-10,9.20790788029057e-08,6.00816741714939e-08,B4GALT1/CCL14/CCL20/CCN3/CD300A/CSF1/CXCL13/F7/IL6/JAM2/LGALS9/NBL1/PGF/PTN/THY1/TNFRSF14/VCAM1/VEGFA,18
GO:0046718,GO:0046718,viral entry into host cell,12/142,146/18800,1.1184954378299202e-09,1.33390937400457e-07,8.70376956689484e-08,CD46/CD55/CD80/CLEC5A/EPHA2/LGALS9/NECTIN2/NECTIN4/SCARB2/TFRC/TNFRSF14/TNFRSF4,12
GO:0002697,GO:0002697,regulation of immune effector process,17/142,353/18800,1.4615915820219701e-09,1.68083031932527e-07,1.09674315703603e-07,CD300A/CD46/CD55/CD59/CD80/HAVCR2/HLA-E/IL6/LGALS9/LILRB4/NECTIN2/SPON2/TFRC/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,17
GO:0002507,GO:0002507,tolerance induction,7/142,31/18800,2.73132776849645e-09,2.93162513818619e-07,1.91288779856804e-07,HAVCR2/HLA-E/IL2RA/LGALS9/LILRB4/PDCD1/TGFBR2,7
GO:0002274,GO:0002274,myeloid leukocyte activation,13/142,232/18800,2.34769709683097e-08,2.23002480605785e-06,1.45509300846403e-06,CD300A/CD93/CSF1/HAVCR2/IFNGR1/IL6/LGALS9/LILRB4/LTBR/NECTIN2/PTGDS/TGFBR2/VSIG4,13
GO:0032496,GO:0032496,response to lipopolysaccharide,15/142,333/18800,3.48016342499268e-08,3.11281284124346e-06,2.03111292289047e-06,ADM/CD14/CD55/CD80/CXCL13/EPO/HAVCR2/IL18BP/IL6/LGALS9/NOS1/NOS3/SPON2/TNFRSF1B/VCAM1,15
GO:0044706,GO:0044706,multi-multicellular organism process,12/142,213/18800,7.85048923067573e-08,6.65225666388838e-06,4.34060290981406e-06,ADM/B4GALT1/EPO/HAVCR2/IGFBP2/IGFBP7/LGALS9/PGF/PTN/TGFBR2/TIMP1/VEGFA,12
GO:0048771,GO:0048771,tissue remodeling,11/142,174/18800,8.68979474529717e-08,7.17465104611715e-06,4.68146567115065e-06,ACVRL1/BGLAP/CST3/EPHA2/IL6/LTBP3/NOS3/PTN/RSPO3/TFRC/TIMP1,11
GO:0050777,GO:0050777,negative regulation of immune response,11/142,179/18800,1.1599034168923e-07,9.01698914151168e-06,5.88359278406581e-06,CD300A/CD46/CD55/CD59/HAVCR2/HLA-E/LGALS9/LILRB4/PDCD1/TNFRSF14/VSIG4,11
GO:0001503,GO:0001503,ossification,16/142,420/18800,1.2034563091885e-07,9.01698914151168e-06,5.88359278406581e-06,BAMBI/BGLAP/CHRDL1/CLEC5A/CRIM1/CSF1/EPHA2/FGF23/FSTL3/IL6/LTBP3/PTN/SMOC1/TNC/VCAN/YAP1,16
GO:0060326,GO:0060326,cell chemotaxis,14/142,315/18800,1.20413209032609e-07,9.01698914151168e-06,5.88359278406581e-06,CCL14/CCL20/CCN3/CSF1/CXCL13/EPHA2/F7/IL6/LGALS9/NBL1/PGF/PTN/VCAM1/VEGFA,14
GO:0042060,GO:0042060,wound healing,16/142,429/18800,1.60481083378473e-07,1.15975290856027e-05,7.56739720655865e-06,ACTA2/ACVRL1/B4GALT1/CD59/F10/F7/IL6/NOS3/OCLN/PLAUR/PROS1/TGFBR2/TIMP1/TNFRSF12A/VEGFA/YAP1,16
GO:0007565,GO:0007565,female pregnancy,11/142,185/18800,1.62077269829851e-07,1.15975290856027e-05,7.56739720655865e-06,ADM/EPO/HAVCR2/IGFBP2/IGFBP7/LGALS9/PGF/PTN/TGFBR2/TIMP1/VEGFA,11
GO:0046631,GO:0046631,alpha-beta T cell activation,10/142,158/18800,3.39258827810868e-07,2.10079504913653e-05,1.37077048645849e-05,CD300A/CD55/CD80/CD83/HLA-E/IL6/LGALS9/LILRB4/TGFBR2/TNFRSF14,10
GO:0045765,GO:0045765,regulation of angiogenesis,14/142,345/18800,3.6428471755024e-07,2.21320149153164e-05,1.44411578198665e-05,ACVRL1/ADAM12/ADM/CXCL13/DLL1/EFNA1/EPHA2/HSPB6/HSPG2/IL6/NOS3/PGF/TGFBR2/VEGFA,14
GO:0002443,GO:0002443,leukocyte mediated immunity,16/142,457/18800,3.75468049068856e-07,2.23890207037355e-05,1.46088543068506e-05,BTN3A2/CD27/CD300A/CD46/CD55/HAVCR2/HLA-E/IL6/LGALS9/LILRB4/NECTIN2/PTGDS/SPON2/TFRC/TNFRSF1B/ULBP2,16
GO:0045582,GO:0045582,positive regulation of T cell differentiation,8/142,94/18800,5.59659132906262e-07,2.95426624255437e-05,1.92766113767196e-05,CD27/CD46/CD80/CD83/IL2RA/LGALS9/LILRB4/TGFBR2,8
GO:0090130,GO:0090130,tissue migration,14/142,366/18800,7.39496440641317e-07,3.77964847438895e-05,2.46622371849636e-05,ACTA2/ACVRL1/CCN3/CLEC14A/CXCL13/EFNA1/EPHA2/EPHB4/FSTL1/NOS3/NRP2/PTN/TGFBR2/VEGFA,14
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,14/142,370/18800,8.41538723477806e-07,4.07563318460284e-05,2.65935398380754e-05,BTN3A2/CD27/CD46/CD55/CD80/CXCL13/HAVCR2/HLA-E/IL18BP/IL6/LILRB4/NECTIN2/TFRC/TNFRSF1B,14
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,16/142,486/18800,8.48035476299348e-07,4.07563318460284e-05,2.65935398380754e-05,CCL14/CCL20/CSF1/CXCL13/EDA2R/EPO/IFNGR1/IL2RA/IL6/LILRB4/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/YAP1,16
GO:1903131,GO:1903131,mononuclear cell differentiation,15/142,433/18800,1.01493652892043e-06,4.66870803303396e-05,3.04633580710552e-05,CD27/CD46/CD79B/CD80/CD83/CSF1/DLL1/IL2RA/IL6/LGALS9/LILRB4/LTBR/TGFBR2/VCAM1/VEGFA,15
GO:0043542,GO:0043542,endothelial cell migration,12/142,279/18800,1.41427116337529e-06,6.41401851558936e-05,4.18515232334631e-05,ACVRL1/CCN3/CLEC14A/CXCL13/EFNA1/EPHA2/EPHB4/FSTL1/NOS3/NRP2/PTN/VEGFA,12
GO:0031099,GO:0031099,regeneration,10/142,188/18800,1.66992161870573e-06,7.26641569220602e-05,4.74134217771926e-05,ADM/CCN3/F7/IL6/NEFL/PGF/PTN/TGFBR2/THY1/YAP1,10
GO:0002456,GO:0002456,T cell mediated immunity,8/142,112/18800,2.13293594367712e-06,8.91955030992251e-05,5.82001386682097e-05,BTN3A2/CD46/CD55/HLA-E/IL6/LILRB4/NECTIN2/TNFRSF1B,8
GO:0001649,GO:0001649,osteoblast differentiation,11/142,241/18800,2.22924383117782e-06,9.20277581588793e-05,6.00481874093243e-05,BAMBI/BGLAP/CLEC5A/CRIM1/EPHA2/FGF23/IL6/SMOC1/TNC/VCAN/YAP1,11
GO:0034612,GO:0034612,response to tumor necrosis factor,11/142,249/18800,3.05614385190608e-06,0.0001185636530498,7.73628805124227e-05,CCL14/CCL20/CD14/EDA2R/IL18BP/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/VCAM1,11
GO:0001819,GO:0001819,positive regulation of cytokine production,15/142,475/18800,3.17714170595386e-06,0.0001217904320615,7.94683564546856e-05,BTN3A2/CD14/CD276/CD46/CD55/CD80/CD83/CLEC5A/HAVCR2/HLA-E/IFNGR1/IL6/LGALS9/SPON2/TNFRSF14,15
GO:0003007,GO:0003007,heart morphogenesis,11/142,254/18800,3.69979826132845e-06,0.0001338578696795,8.73423693626444e-05,ACVRL1/DLL1/EFNA1/ELN/EPHB4/FLRT2/NOS3/NRP2/TGFBR2/VEGFA/YAP1,11
GO:0042742,GO:0042742,defense response to bacterium,13/142,364/18800,3.98319815625681e-06,0.0001425099784794,9.29878774255976e-05,CCL20/COLEC12/CXCL13/EPHA2/HAVCR2/HLA-E/IL6/LCN2/RNASE6/SPON2/TNFRSF14/TNFRSF1A/WFDC2,13
GO:0043410,GO:0043410,positive regulation of MAPK cascade,15/142,491/18800,4.74741186585978e-06,0.0001626241085964,0.0001061123637654,ACTA2/CCL14/CCL20/CD27/EDA2R/EFNA1/EPO/FGF23/HAVCR2/IGFBP4/IL6/LGALS9/LTBR/TNFRSF19/VEGFA,15
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,9/142,167/18800,5.04983791988061e-06,0.0001676337948661,0.0001093811881506,CD55/HLA-E/IL6/LILRB4/SPON2/TFRC/TNFRSF14/TNFRSF1B/TNFRSF4,9
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,13/142,373/18800,5.19193034737179e-06,0.000168693026609,0.0001100723377285,CD300A/CD80/EFEMP1/EFNA1/EPHA2/EPHB4/EPO/IL6/LILRB4/THY1/TNFRSF14/TNFRSF1A/VEGFA,13
GO:0006959,GO:0006959,humoral immune response,12/142,317/18800,5.28116744988736e-06,0.000168693026609,0.0001100723377285,CD46/CD55/CD59/CD83/CXCL13/HLA-E/IL6/PDCD1/RNASE6/SPON2/VSIG4/WFDC2,12
GO:0035633,GO:0035633,maintenance of blood-brain barrier,5/142,35/18800,6.19628936575553e-06,0.0001937092403663,0.0001263954376499,ESAM/IL6/JAM2/OCLN/VEGFA,5
GO:0032613,GO:0032613,interleukin-10 production,6/142,63/18800,7.96460095585218e-06,0.0002419435384702,0.0001578683565827,CD46/CD83/DLL1/IL6/LGALS9/LILRB4,6
GO:0003176,GO:0003176,aortic valve development,5/142,37/18800,8.21965475707094e-06,0.0002422805978549,0.0001580882881067,EFNA1/ELN/NOS3/TNFRSF1A/TNFRSF1B,5
GO:0050920,GO:0050920,regulation of chemotaxis,10/142,225/18800,8.27666638634903e-06,0.0002422805978549,0.0001580882881067,CCN3/CSF1/CXCL13/F7/IL6/LGALS9/NBL1/PGF/PTN/VEGFA,10
GO:0002367,GO:0002367,cytokine production involved in immune response,7/142,100/18800,1.0776914473469e-05,0.0002891805383714,0.0001886905376231,CD55/HLA-E/IL6/LILRB4/SPON2/TNFRSF14/TNFRSF1B,7
GO:0001666,GO:0001666,response to hypoxia,11/142,286/18800,1.13969263277159e-05,0.0003008041211085,0.0001962749348586,ACVRL1/ADM/EPO/F7/HYOU1/NOS1/PGF/TFRC/TGFBR2/VCAM1/VEGFA,11
GO:0030510,GO:0030510,regulation of BMP signaling pathway,7/142,105/18800,1.48504960566059e-05,0.0003765243882068,0.0002456824710235,ACVRL1/BAMBI/CHRDL1/CRIM1/FSTL1/FSTL3/NBL1,7
GO:0006898,GO:0006898,receptor-mediated endocytosis,10/142,246/18800,1.79774425927648e-05,0.0004418882835778,0.0002883324661724,ADM/CD14/DLL1/HSPG2/LILRB4/RSPO1/SCARB2/TFRC/TGFBR2/VEGFA,10
GO:0007584,GO:0007584,response to nutrient,8/142,150/18800,1.85415723480142e-05,0.0004523019921258,0.0002951274195106,BGLAP/EPO/F7/FGF23/IGFBP2/TFRC/TGFBR2/VCAM1,8
GO:0036303,GO:0036303,lymph vessel morphogenesis,4/142,23/18800,2.47073512089974e-05,0.0005765048615432,0.0003761698933116,ACVRL1/CLEC14A/EPHA2/VEGFA,4
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,8/142,161/18800,3.08707900688528e-05,0.0007049925107922,0.0004600081894544,CD300A/CD80/HAVCR2/IL2RA/LGALS9/LILRB4/TNFRSF14/VSIG4,8
GO:0060249,GO:0060249,anatomical structure homeostasis,11/142,319/18800,3.12971213616556e-05,0.000709695287215,0.0004630767549137,BGLAP/CSF1/ESAM/IL6/JAM2/LTBP3/NOS3/OCLN/TFRC/VEGFA/YAP1,11
GO:0007568,GO:0007568,aging,8/142,163/18800,3.37216515062072e-05,0.0007566187261774,0.0004936943371854,ADM/EPO/IGFBP2/TFRC/TGFBR2/TIMP1/TNFRSF1B/VCAM1,8
GO:0070231,GO:0070231,T cell apoptotic process,5/142,50/18800,3.69256221685271e-05,0.0008033817796125,0.0005242072677694,CD27/EFNA1/IL2RA/LGALS9/PDCD1,5
GO:0002709,GO:0002709,regulation of T cell mediated immunity,6/142,88/18800,5.4426941548487e-05,0.001130675817975,0.0007377668952854,CD55/HLA-E/IL6/LILRB4/NECTIN2/TNFRSF1B,6
GO:0007219,GO:0007219,Notch signaling pathway,8/142,182/18800,7.36007171865028e-05,0.0014629278354354,0.0009545616082148,CCN3/CD46/DLL1/DTX3/IL2RA/NOS3/TGFBR2/YAP1,8
GO:0002040,GO:0002040,sprouting angiogenesis,8/142,186/18800,8.56890947463513e-05,0.0016621619583328,0.0010845620362315,ACVRL1/CLEC14A/DLL1/EPHA2/EPHB4/PGF/RSPO3/VEGFA,8
GO:0051384,GO:0051384,response to glucocorticoid,7/142,139/18800,8.99733941042345e-05,0.0016942358421967,0.0011054902716654,ADM/BGLAP/EPO/IGFBP2/IGFBP7/IL6/NEFL,7
GO:0032102,GO:0032102,negative regulation of response to external stimulus,12/142,429/18800,0.0001026975868905,0.0019114810970372,0.0012472429779949,CCN3/CXCL13/HAVCR2/HLA-E/IL2RA/LGALS9/NBL1/NOS3/PROS1/TNFRSF1A/TNFRSF1B/VSIG4,12
GO:0031341,GO:0031341,regulation of cell killing,6/142,100/18800,0.0001111731588403,0.0019868452309454,0.0012964181369621,CD55/CD59/HAVCR2/HLA-E/LGALS9/NECTIN2,6
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,3/142,13/18800,0.0001141510458772,0.0019868452309454,0.0012964181369621,CST3/TNFRSF1A/TNFRSF1B,3
GO:0051346,GO:0051346,negative regulation of hydrolase activity,11/142,371/18800,0.0001210771082138,0.0020669138601495,0.0013486629829547,CD27/COL6A3/CRIM1/CST3/NOS1/NOS3/PLAUR/PROS1/TIMP1/VEGFA/WFDC2,11
GO:0070232,GO:0070232,regulation of T cell apoptotic process,4/142,34/18800,0.0001213188570087,0.0020669138601495,0.0013486629829547,CD27/EFNA1/LGALS9/PDCD1,4
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,9/142,251/18800,0.0001247839077493,0.0021033255496859,0.001372421640135,CD27/COL6A3/CRIM1/CST3/PLAUR/PROS1/TIMP1/VEGFA/WFDC2,9
GO:0031100,GO:0031100,animal organ regeneration,5/142,65/18800,0.0001314648804626,0.002193351891657,0.0014311639018462,ADM/F7/IL6/PGF/TGFBR2,5
GO:0032103,GO:0032103,positive regulation of response to external stimulus,12/142,442/18800,0.0001358107767541,0.0022537206937481,0.0014705545945476,CSF1/CXCL13/F7/HAVCR2/HLA-E/IL6/LGALS9/NECTIN2/PGF/PTN/TNFRSF1A/VEGFA,12
GO:0071216,GO:0071216,cellular response to biotic stimulus,9/142,256/18800,0.0001447813251953,0.0023309793356453,0.001520965921526,CD14/CD55/CD80/CXCL13/HAVCR2/IL6/NOS3/SPON2/TNFRSF1B,9
GO:0009612,GO:0009612,response to mechanical stimulus,8/142,201/18800,0.0001466550511796,0.0023493993273549,0.0015329849811704,BGLAP/IGFBP2/LRP11/LTBR/PTN/TGFBR2/TNFRSF10B/TNFRSF1A,8
GO:0043627,GO:0043627,response to estrogen,5/142,68/18800,0.0001629309185425,0.0025592075985713,0.0016698850496072,BGLAP/EPO/F7/IGFBP2/TGFBR2,5
GO:0014028,GO:0014028,notochord formation,2/142,3/18800,0.0001691120065044,0.0026280996747313,0.0017148371856043,EFNA1/EPHA2,2
GO:0033594,GO:0033594,response to hydroxyisoflavone,2/142,3/18800,0.0001691120065044,0.0026280996747313,0.0017148371856043,BGLAP/F7,2
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,5/142,72/18800,0.0002134710809577,0.0031387072177348,0.0020480090247135,HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,5
GO:0002526,GO:0002526,acute inflammatory response,6/142,113/18800,0.0002174870924074,0.0031832201706911,0.0020770537628962,B4GALT1/EPO/HLA-E/IL6/TFRC/VCAM1,6
GO:0090288,GO:0090288,negative regulation of cellular response to growth factor stimulus,6/142,115/18800,0.0002392412783848,0.0034700761999965,0.0022642275564541,BAMBI/CHRDL1/CRIM1/CXCL13/FSTL3/NBL1,6
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,5/142,74/18800,0.0002428246495031,0.003506257270852,0.0022878357347566,DLL1/NRP2/PGF/VCAM1/VEGFA,5
GO:1903034,GO:1903034,regulation of response to wounding,7/142,166/18800,0.0002700830131315,0.0037811621838416,0.0024672114151513,ACTA2/F7/NOS3/OCLN/PROS1/PTN/TNFRSF12A,7
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,8/142,221/18800,0.000279720263755,0.0038991309493133,0.0025441861310328,CD27/LTBR/NOS3/TNFRSF10B/TNFRSF12A/TNFRSF1A/TNFRSF1B/YAP1,8
GO:0048872,GO:0048872,homeostasis of number of cells,9/142,282/18800,0.0002970981893138,0.0041058204703458,0.0026790512124257,CCN3/CSF1/EPO/FSTL1/IL2RA/IL6/LGALS9/NOS3/VEGFA,9
GO:0002366,GO:0002366,leukocyte activation involved in immune response,9/142,285/18800,0.0003210665999854,0.004380654457428,0.0028583806136078,CD300A/CD46/CD80/DLL1/HAVCR2/IL6/LGALS9/PTGDS/TFRC,9
GO:0003332,GO:0003332,negative regulation of extracellular matrix constituent secretion,2/142,4/18800,0.00033654568865,0.0045153213227211,0.0029462508532695,TNFRSF1A/TNFRSF1B,2
GO:0022612,GO:0022612,gland morphogenesis,6/142,123/18800,0.0003439488926319,0.0045797607464303,0.0029882976299035,CSF1/EPHA2/IL6/PTN/TGFBR2/TNC,6
GO:0071772,GO:0071772,response to BMP,7/142,173/18800,0.0003470377708475,0.0045797607464303,0.0029882976299035,ACVRL1/BAMBI/CHRDL1/CRIM1/FSTL1/FSTL3/NBL1,7
GO:0001570,GO:0001570,vasculogenesis,5/142,80/18800,0.0003494991427928,0.0045934173052772,0.0029972085457121,ADM/EPHA2/TGFBR2/VEGFA/YAP1,5
GO:0010632,GO:0010632,regulation of epithelial cell migration,9/142,290/18800,0.0003645610538895,0.0047467520322675,0.0030972595803877,ACVRL1/CXCL13/EFNA1/EPHA2/NOS3/NRP2/PTN/TGFBR2/VEGFA,9
GO:0010594,GO:0010594,regulation of endothelial cell migration,8/142,230/18800,0.0003655883552802,0.0047467520322675,0.0030972595803877,ACVRL1/CXCL13/EFNA1/EPHA2/NOS3/NRP2/PTN/VEGFA,8
GO:0045953,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,3/142,19/18800,0.0003741157302436,0.0048186106055381,0.0031441473581739,HAVCR2/HLA-E/LGALS9,3
GO:0052548,GO:0052548,regulation of endopeptidase activity,11/142,426/18800,0.0003973206434093,0.0050649788760882,0.0033049028560549,CD27/COL6A3/CRIM1/CST3/EFNA1/LGALS9/PLAUR/PROS1/TIMP1/VEGFA/WFDC2,11
GO:0060485,GO:0060485,mesenchyme development,9/142,301/18800,0.0004775471472951,0.0059370726420478,0.0038739447510714,ACTA2/ACVRL1/BAMBI/EFNA1/IL6/NOS3/NRP2/TGFBR2/YAP1,9
GO:0034103,GO:0034103,regulation of tissue remodeling,5/142,86/18800,0.000488330355313,0.0060477836311849,0.0039461837619631,BGLAP/CST3/IL6/LTBP3/TFRC,5
GO:0001906,GO:0001906,cell killing,7/142,185/18800,0.0005191204913372,0.006317401719505,0.0041221097849402,CD55/CD59/HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,7
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,7/142,185/18800,0.0005191204913372,0.006317401719505,0.0041221097849402,ADM/CSF1/EPHA2/RSPO3/TGFBR2/VEGFA/YAP1,7
GO:0030857,GO:0030857,negative regulation of epithelial cell differentiation,4/142,50/18800,0.0005486761416708,0.0065193253733578,0.0042538651341034,ACVRL1/DLL1/VEGFA/YAP1,4
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,4/142,50/18800,0.0005486761416708,0.0065193253733578,0.0042538651341034,DLL1/NRP2/PGF/VEGFA,4
GO:0050673,GO:0050673,epithelial cell proliferation,11/142,443/18800,0.0005509038397167,0.0065217292789997,0.0042554336844993,ACVRL1/B4GALT1/CCN3/EPHA2/IGFBP4/IL6/NRP2/PGF/PTN/VEGFA/YAP1,11
GO:0036324,GO:0036324,vascular endothelial growth factor receptor-2 signaling pathway,2/142,5/18800,0.0005581277822945,0.0065351689417766,0.0042642030754449,CLEC14A/VEGFA,2
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/142,5/18800,0.0005581277822945,0.0065351689417766,0.0042642030754449,TNFRSF1A/TNFRSF1B,2
GO:0002440,GO:0002440,production of molecular mediator of immune response,9/142,312/18800,0.0006178884850806,0.0070804303272588,0.0046199865750927,CD55/HLA-E/IL6/LILRB4/SPON2/TFRC/TNFRSF14/TNFRSF1B/TNFRSF4,9
GO:0048013,GO:0048013,ephrin receptor signaling pathway,4/142,52/18800,0.000637505454569,0.0072535956314918,0.0047329770776259,EFNA1/EFNA4/EPHA2/EPHB4,4
GO:0001763,GO:0001763,morphogenesis of a branching structure,7/142,199/18800,0.0007993145992602,0.0088143596219797,0.0057513768569701,ADM/CSF1/EPHA2/RSPO3/TGFBR2/VEGFA/YAP1,7
GO:0061448,GO:0061448,connective tissue development,8/142,260/18800,0.0008188758117267,0.0089992495350179,0.0058720176763307,ACTA2/ACVRL1/CCN3/CSF1/EFEMP1/LTBP3/TGFBR2/TIMP1,8
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/142,6/18800,0.0008330422513647,0.0090621488155221,0.0059130595082648,HAVCR2/LGALS9,2
GO:0001911,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,3/142,25/18800,0.0008590288980469,0.0091289539660438,0.0059566499235775,HAVCR2/HLA-E/LGALS9,3
GO:1902993,GO:1902993,positive regulation of amyloid precursor protein catabolic process,3/142,25/18800,0.0008590288980469,0.0091289539660438,0.0059566499235775,EFNA1/IFNGR1/SPON1,3
GO:0002064,GO:0002064,epithelial cell development,7/142,203/18800,0.0008981107870125,0.0094816942104274,0.0061868132213184,ACTA2/B4GALT1/DLL1/EPHA2/TNFRSF1A/VEGFA/YAP1,7
GO:0002026,GO:0002026,regulation of the force of heart contraction,3/142,26/18800,0.0009657301488915,0.0100635957263132,0.006566504435999,ADM/NOS1/NOS3,3
GO:0031348,GO:0031348,negative regulation of defense response,8/142,268/18800,0.0009956350748715,0.0103417578744725,0.0067480054650039,CCN3/HAVCR2/HLA-E/IL2RA/LGALS9/TNFRSF1A/TNFRSF1B/VSIG4,8
GO:0070167,GO:0070167,regulation of biomineral tissue development,5/142,101/18800,0.0010147991320035,0.0105069234889117,0.0068557761634089,BGLAP/FGF23/LTBP3/NOS3/PTN,5
GO:0031102,GO:0031102,neuron projection regeneration,4/142,59/18800,0.0010288969654121,0.0105848186218121,0.0069066028012869,ADM/NEFL/PTN/THY1,4
GO:0110149,GO:0110149,regulation of biomineralization,5/142,103/18800,0.0011081536809498,0.0112209272096181,0.0073216641746968,BGLAP/FGF23/LTBP3/NOS3/PTN,5
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,7/142,211/18800,0.0011245078023992,0.0113508311088579,0.0074064265751161,ACVRL1/B4GALT1/NRP2/PGF/PTN/VEGFA/YAP1,7
GO:0043305,GO:0043305,negative regulation of mast cell degranulation,2/142,7/18800,0.0011604821474615,0.0116048214746151,0.007572155496349,CD300A/LGALS9,2
GO:0090027,GO:0090027,negative regulation of monocyte chemotaxis,2/142,7/18800,0.0011604821474615,0.0116048214746151,0.007572155496349,CCN3/NBL1,2
GO:1901890,GO:1901890,positive regulation of cell junction assembly,5/142,105/18800,0.0012077287393525,0.0119290998181444,0.0077837473805217,AGRN/EPHA2/FLRT2/THY1/VEGFA,5
GO:0009408,GO:0009408,response to heat,5/142,109/18800,0.0014265469561113,0.0138313336093331,0.009024956483893,CD14/IGFBP7/LRP11/NOS1/NOS3,5
GO:0007596,GO:0007596,blood coagulation,7/142,221/18800,0.0014680217675257,0.0141103858188211,0.0092070382786423,CD59/F10/F7/IL6/NOS3/PLAUR/PROS1,7
GO:0002062,GO:0002062,chondrocyte differentiation,5/142,110/18800,0.0014855344076336,0.0141103858188211,0.0092070382786423,ACVRL1/CCN3/EFEMP1/LTBP3/TGFBR2,5
GO:1905603,GO:1905603,regulation of blood-brain barrier permeability,2/142,8/18800,0.0015396495207143,0.0143700621933343,0.0093764773252354,OCLN/VEGFA,2
GO:0050817,GO:0050817,coagulation,7/142,226/18800,0.0016679697021179,0.0153016023954981,0.0099843080684583,CD59/F10/F7/IL6/NOS3/PLAUR/PROS1,7
GO:0031623,GO:0031623,receptor internalization,5/142,113/18800,0.0016732893064932,0.0153067942241714,0.0099876957409107,ADM/LILRB4/RSPO1/TFRC/VEGFA,5
GO:0007599,GO:0007599,hemostasis,7/142,227/18800,0.0017103867433728,0.0155577551233348,0.0101514479327154,CD59/F10/F7/IL6/NOS3/PLAUR/PROS1,7
GO:0033028,GO:0033028,myeloid cell apoptotic process,3/142,32/18800,0.0017823645585941,0.0160762293520254,0.0104897527906645,CLEC5A/EPO/IL6,3
GO:0048639,GO:0048639,positive regulation of developmental growth,6/142,169/18800,0.0018053712057327,0.0162146000625109,0.0105800397923412,AGRN/CSF1/DLL1/TGFBR2/VEGFA/YAP1,6
GO:0045446,GO:0045446,endothelial cell differentiation,5/142,117/18800,0.0019500224956291,0.0171421950466661,0.0111852962775892,ACVRL1/DLL1/FSTL1/TNFRSF1A/VEGFA,5
GO:1904238,GO:1904238,pericyte cell differentiation,2/142,9/18800,0.0019697553314492,0.0171421950466661,0.0111852962775892,ACTA2/EPHA2,2
GO:0030278,GO:0030278,regulation of ossification,5/142,118/18800,0.0020241364899021,0.0174888450466867,0.0114114856859061,BGLAP/CSF1/FGF23/LTBP3/PTN,5
GO:0007411,GO:0007411,axon guidance,7/142,234/18800,0.0020313130582176,0.0174888450466867,0.0114114856859061,EFNA1/EFNA4/EPHA2/EPHB4/FLRT2/NRP2/VEGFA,7
GO:0042246,GO:0042246,tissue regeneration,4/142,72/18800,0.0021564601878378,0.0184185724266259,0.0120181335611459,CCN3/PTN/TGFBR2/YAP1,4
GO:0001654,GO:0001654,eye development,9/142,379/18800,0.0023783432786398,0.0201482992137649,0.0131467817033916,ACVRL1/CHRDL1/DLL1/EFEMP1/EPHA2/SMOC1/TGFBR2/THY1/VEGFA,9
GO:0033007,GO:0033007,negative regulation of mast cell activation involved in immune response,2/142,10/18800,0.0024500193626618,0.020491071033172,0.0133704405956885,CD300A/LGALS9,2
GO:0006527,GO:0006527,arginine catabolic process,2/142,11/18800,0.0029796701332914,0.0238670095253689,0.0155732432208684,NOS1/NOS3,2
GO:0031284,GO:0031284,positive regulation of guanylate cyclase activity,2/142,11/18800,0.0029796701332914,0.0238670095253689,0.0155732432208684,NOS1/NOS3,2
GO:0097084,GO:0097084,vascular associated smooth muscle cell development,2/142,11/18800,0.0029796701332914,0.0238670095253689,0.0155732432208684,ADM/VEGFA,2
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,5/142,131/18800,0.0031851061724492,0.0253862422655612,0.0165645438254528,HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,5
GO:0033674,GO:0033674,positive regulation of kinase activity,10/142,476/18800,0.0033458023901578,0.0264055972948729,0.0172296738151574,CD300A/CSF1/EFNA1/EPHA2/EPHB4/EPO/PILRB/TGFBR2/TNFRSF10B/VEGFA,10
GO:0003158,GO:0003158,endothelium development,5/142,133/18800,0.0033989236472801,0.0267592521864111,0.0174604339209142,ACVRL1/DLL1/FSTL1/TNFRSF1A/VEGFA,5
GO:0003018,GO:0003018,vascular process in circulatory system,7/142,263/18800,0.0038839347974987,0.0293758030816323,0.0191677355184498,ACTA2/ADM/NOS1/NOS3/OCLN/TFRC/VEGFA,7
GO:0051602,GO:0051602,response to electrical stimulus,3/142,42/18800,0.003904609850602,0.0293758030816323,0.0191677355184498,CD14/EPO/PALM,3
GO:0071354,GO:0071354,cellular response to interleukin-6,3/142,42/18800,0.003904609850602,0.0293758030816323,0.0191677355184498,FGF23/IL6/YAP1,3
GO:0042113,GO:0042113,B cell activation,8/142,336/18800,0.0040547399867433,0.0301530317720866,0.0196748778741696,CD27/CD300A/CD79B/DLL1/IL6/TFRC/TNFRSF4/VCAM1,8
GO:0033627,GO:0033627,cell adhesion mediated by integrin,4/142,86/18800,0.0041042878752025,0.0303440698416902,0.0197995303707138,CCN3/CXCL13/EFNA1/EPHA2,4
GO:0014002,GO:0014002,astrocyte development,3/142,43/18800,0.0041744843485306,0.0303440698416902,0.0197995303707138,DLL1/IFNGR1/IL6,3
GO:0010713,GO:0010713,negative regulation of collagen metabolic process,2/142,13/18800,0.0041840891334504,0.0303440698416902,0.0197995303707138,CST3/IL6,2
GO:0060670,GO:0060670,branching involved in labyrinthine layer morphogenesis,2/142,13/18800,0.0041840891334504,0.0303440698416902,0.0197995303707138,ADM/RSPO3,2
GO:0044089,GO:0044089,positive regulation of cellular component biogenesis,10/142,494/18800,0.0043416130610402,0.0313452781536988,0.0204528196125475,AGRN/CXCL13/EPHA2/FLRT2/LMOD1/OCLN/PALM/TFRC/THY1/VEGFA,10
GO:0070555,GO:0070555,response to interleukin-1,5/142,141/18800,0.0043582581061165,0.0313950583930541,0.0204853012594103,CCL14/CCL20/EPO/IL6/LGALS9,5
GO:0031346,GO:0031346,positive regulation of cell projection organization,8/142,341/18800,0.0044283908558715,0.0318290592765765,0.0207684871906005,AGRN/EPO/NEFL/OCLN/PALM/PTN/SCARB2/VEGFA,8
GO:0007520,GO:0007520,myoblast fusion,3/142,45/18800,0.0047475645832444,0.0335244692062434,0.0218747435552997,ADAM12/JAM2/NOS1,3
GO:0033033,GO:0033033,negative regulation of myeloid cell apoptotic process,2/142,14/18800,0.0048573573110819,0.033781189074911,0.0220422534794124,CLEC5A/EPO,2
GO:0043301,GO:0043301,negative regulation of leukocyte degranulation,2/142,14/18800,0.0048573573110819,0.033781189074911,0.0220422534794124,CD300A/LGALS9,2
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/142,14/18800,0.0048573573110819,0.033781189074911,0.0220422534794124,TNFRSF1A/TNFRSF1B,2
GO:0070741,GO:0070741,response to interleukin-6,3/142,46/18800,0.0050510251849141,0.0350523730504817,0.0228717020623607,FGF23/IL6/YAP1,3
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,7/142,279/18800,0.0053438745667647,0.0367623155102058,0.0239874409147992,DSC2/ESAM/NECTIN2/NECTIN4/SPARCL1/TGFBR2/VCAM1,7
GO:0051146,GO:0051146,striated muscle cell differentiation,7/142,281/18800,0.0055518802013389,0.0377950406941041,0.0246612949412984,ADAM12/CCN3/DLL1/JAM2/LMOD1/NOS1/VEGFA,7
GO:0033628,GO:0033628,regulation of cell adhesion mediated by integrin,3/142,48/18800,0.0056923887337281,0.0381070513983463,0.0248648821808104,CXCL13/EFNA1/EPHA2,3
GO:0050767,GO:0050767,regulation of neurogenesis,8/142,361/18800,0.0061946604263376,0.0411274362325925,0.0268356857535974,DLL1/IL6/NEFL/PTN/THY1/TNFRSF1B/VEGFA/YAP1,8
GO:0030002,GO:0030002,cellular anion homeostasis,2/142,16/18800,0.0063423239945387,0.0413406543773576,0.0269748107673115,CKB/FGF23,2
GO:0043303,GO:0043303,mast cell degranulation,3/142,50/18800,0.0063804230689485,0.0414212949234159,0.0270274287895188,CD300A/LGALS9/PTGDS,3
GO:0002544,GO:0002544,chronic inflammatory response,2/142,17/18800,0.0071525725828248,0.0433534342170113,0.0282881512576511,CXCL13/VCAM1,2
GO:0048532,GO:0048532,anatomical structure arrangement,2/142,17/18800,0.0071525725828248,0.0433534342170113,0.0282881512576511,DLL1/NRP2,2
GO:0048569,GO:0048569,post-embryonic animal organ development,2/142,17/18800,0.0071525725828248,0.0433534342170113,0.0282881512576511,EFEMP1/VEGFA,2
GO:0090713,GO:0090713,immunological memory process,2/142,17/18800,0.0071525725828248,0.0433534342170113,0.0282881512576511,CD46/TNFRSF14,2
GO:0010717,GO:0010717,regulation of epithelial to mesenchymal transition,4/142,102/18800,0.0074883884167519,0.0433534342170113,0.0282881512576511,BAMBI/EFNA1/IL6/TGFBR2,4
GO:0010718,GO:0010718,positive regulation of epithelial to mesenchymal transition,3/142,53/18800,0.0075017878249113,0.0433534342170113,0.0282881512576511,BAMBI/IL6/TGFBR2,3
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,HLA-E,1
GO:0010711,GO:0010711,negative regulation of collagen catabolic process,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CST3,1
GO:0014740,GO:0014740,negative regulation of muscle hyperplasia,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,NOS3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,DLL1,1
GO:0045584,GO:0045584,negative regulation of cytotoxic T cell differentiation,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,LILRB4,1
GO:0045887,GO:0045887,positive regulation of synaptic assembly at neuromuscular junction,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,AGRN,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,NECTIN2,1
GO:0060101,GO:0060101,"negative regulation of phagocytosis, engulfment",1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CD300A,1
GO:0060311,GO:0060311,negative regulation of elastin catabolic process,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CST3,1
GO:0060611,GO:0060611,mammary gland fat development,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CSF1,1
GO:0060739,GO:0060739,mesenchymal-epithelial cell signaling involved in prostate gland development,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,TNC,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,DLL1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,VCAM1,1
GO:0061476,GO:0061476,response to anticoagulant,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,F7,1
GO:0061872,GO:0061872,hepatic stellate cell contraction,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,ACTA2,1
GO:0061873,GO:0061873,regulation of hepatic stellate cell contraction,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,ACTA2,1
GO:0061874,GO:0061874,positive regulation of hepatic stellate cell contraction,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,ACTA2,1
GO:0090143,GO:0090143,nucleoid organization,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CHCHD10,1
GO:0090144,GO:0090144,mitochondrial nucleoid organization,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CHCHD10,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CSF1,1
GO:1902569,GO:1902569,negative regulation of activation of Janus kinase activity,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CD300A,1
GO:1904400,GO:1904400,response to Thyroid stimulating hormone,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,F7,1
GO:1905154,GO:1905154,negative regulation of membrane invagination,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,CD300A,1
GO:1905217,GO:1905217,response to astaxanthin,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,F7,1
GO:2000184,GO:2000184,positive regulation of progesterone biosynthetic process,1/142,1/18800,0.0075531914893612,0.0433534342170113,0.0282881512576511,ADM,1
GO:0032026,GO:0032026,response to magnesium ion,2/142,18/18800,0.0080070450290997,0.045552446985338,0.0297230088861506,CD14/FGF23,2
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,2/142,18/18800,0.0080070450290997,0.045552446985338,0.0297230088861506,COLEC12/HAVCR2,2
GO:0001954,GO:0001954,positive regulation of cell-matrix adhesion,3/142,55/18800,0.0083099963605367,0.0470266929366051,0.0306849555741954,CSF1/THY1/VEGFA,3
GO:0033002,GO:0033002,muscle cell proliferation,6/142,233/18800,0.008603864499725,0.0486042871738855,0.0317143371033264,CCN3/ELN/IL6/NOS3/TGFBR2/YAP1,6
GO:0034205,GO:0034205,amyloid-beta formation,3/142,56/18800,0.008732545360742,0.0490729425158626,0.03202013509698,EFNA1/IFNGR1/SPON1,3
GO:0043113,GO:0043113,receptor clustering,3/142,56/18800,0.008732545360742,0.0490729425158626,0.03202013509698,AGRN/PTN/THY1,3
GO:0031645,GO:0031645,negative regulation of nervous system process,2/142,19/18800,0.0089050367113181,0.0496953521844791,0.0324262579144231,CCN3/JAM2,2
